Ticker >

Innova Captab share price

Innova Captab Ltd.

NSE: INNOVACAP BSE: 544067 SECTOR: Pharmaceuticals & Drugs  4923   12   3

485.75
+1.90 (0.39%)
NSE: Today, 03:59 PM

Price Summary

Today's High

₹ 490

Today's Low

₹ 468.25

52 Week High

₹ 588

52 Week Low

₹ 443.25

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

2779.7 Cr.

Enterprise Value

2999.9 Cr.

No. of Shares

5.72 Cr.

P/E

48.3

P/B

3.04

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  159.52

CASH

14.99 Cr.

DEBT

235.19 Cr.

Promoter Holding

50.9 %

EPS (TTM)

₹  10.06

Sales Growth

9.32%

ROE

24.02 %

ROCE

21.7%

Profit Growth

-13.03 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year9.32%
3 Year32%
5 YearNA

Profit Growth

1 Year-12.9%
3 Year27.3%
5 YearNA

ROE%

1 Year24.02%
3 Year29.43%
5 Year28.13%

ROCE %

1 Year21.7%
3 Year27.57%
5 Year25.7%

Debt/Equity

0.8765

Price to Cash Flow

70.77

Interest Cover Ratio

5.27907103825137

CFO/PAT (5 Yr. Avg.)

0.919804740928157

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 50.9 0
Dec 2023 50.9 0
Sep 2023 50.9 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 27.3184665205998% for the Past 3 years.
  • The company has shown a good revenue growth of 32.0021416861698% for the Past 3 years.
  • Company has been maintaining healthy ROE of 29.4261352632147% over the past 3 years.
  • Company has been maintaining healthy ROCE of 27.5699472525943% over the past 3 years.
  • The company has an efficient Cash Conversion Cycle of 28.9986781548663 days.
  • The company has a high promoter holding of 50.9%.

 Limitations

 Looks like the company does not have any serious limitations.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023
Net Sales 211.73 236.46
Total Expenditure 185.45 205.94
Operating Profit 26.29 30.52
Other Income 2.11 1.77
Interest 5.2 3.81
Depreciation 2.81 2.97
Exceptional Items 0 0
Profit Before Tax 20.38 25.51
Tax 5.91 6.86
Profit After Tax 14.47 18.65
Adjusted EPS (Rs) 3.02 3.26

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 356.78 373.32 410.66 785.46 858.67
Total Expenditure 317.11 322.39 356.18 686.95 760.14
Operating Profit 39.68 50.93 54.49 98.51 98.53
Other Income 0.43 1.3 1.37 2.86 8.73
Interest 5.41 4.63 3.93 5.33 18.3
Depreciation 10.67 10.08 5.59 7.4 10.66
Exceptional Items 0 0 0 0 0
Profit Before Tax 24.03 37.53 46.34 88.63 78.31
Tax 4.85 9.64 11.84 22.46 20.76
Net Profit 19.18 27.87 34.42 66.01 57.49
Adjusted EPS (Rs.) 4 5.81 7.19 13.79 11.99

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 12 12 12 12 48
Total Reserves 70.05 98.35 132.82 198.83 220.32
Borrowings 39.48 11.61 6 67.35 134.18
Other N/C liabilities 2.51 2.81 3.64 16.74 57.31
Current liabilities 103.52 129.36 215.15 261.56 259.32
Total Liabilities 227.56 254.13 369.62 556.49 719.13
Assets
Net Block 78.5 73.16 79.14 161.21 161.37
Capital WIP 0 0 7.26 0.03 21.54
Intangible WIP 0 0 0 0 0
Investments 0 0 0 60 60
Loans & Advances 0.34 0.85 12.75 21.69 97.58
Other N/C Assets 0 0 0 0.28 0.26
Current Assets 148.72 180.13 270.46 313.28 378.38
Total Assets 227.56 254.13 369.62 556.49 719.13
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 24.03 37.53 46.34 88.63 78.31
Adjustment 16.06 14.46 9.59 12.41 23.14
Changes in Assets & Liabilities -17.48 -11.99 -1.14 -21.87 -43.26
Tax Paid -3.75 -9.2 -13.23 -20.84 -18.91
Operating Cash Flow 18.86 30.8 41.56 58.34 39.28
Investing Cash Flow -8.98 -6.04 -19.67 -188.33 -87.53
Financing Cash Flow -9.88 -23.28 -19.34 125.3 51.29
Net Cash Flow -0.01 1.48 2.56 -4.69 3.03

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024%
promoters 50.90 50.90 50.90
chhavi lohariwala 0.01 0.01 0.01
manoj lohariwala - - 29.07
vandana lohariwala 0.01 0.01 0.01
vinay kumar lohariwala 21.81 21.81 21.81
manoj kumar lohariwala - 29.07 -
manoj lohariwala 29.07 - -
PARTICULARS Sep 2023% Dec 2023% Mar 2024%
investors 49.10 49.10 49.10
360 one special opportuni... - - 1.72
360 one special opportuni... 1.60 1.60 1.60
canara robeco mutual fund... - - 3.55
gian parkash aggarwal 21.65 21.65 21.65
invesco india midcap fund... - - 2.47
kotak debt hybrid - - 4.02
sbi life insurance co. lt... - - 2.30
uti multi opportunities f... - - 1.60
whiteoak capital flexi ca... - - 1.27
uti multi opportunities f... - 2.47 -
uti multi opportunities f... 2.47 - -

Annual Reports

No Annual reports exist for this company.Report us

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

  • PresentationQ3FY24 15 Feb 2024

Innova Captab Stock Price Analysis and Quick Research Report. Is Innova Captab an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Innova Captab and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Innova Captab cash from the operating activity was Rs 39.279 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Innova Captab has a Debt to Equity ratio of 0.8765 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Innova Captab , the EPS growth was -13.0346483306859 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Innova Captab has OPM of 11.474565987285 % which is a bad sign for profitability.
     
  • ROE: Innova Captab have a healthy ROE of 24.0226903225941 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Innova Captab is Rs 482. One can use valuation calculators of ticker to know if Innova Captab share price is undervalued or overvalued.
Last Updated on:
Brief about Innova Captab
X